Article Details
Retrieved on: 2025-08-21 15:02:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A refinancing deal will delay the maturity of $700 million in debt until 2030, allowing the company to “fully fund” its pipeline and meet its ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here